Medical Devices

Netupitant-Palonosetron FDC Market - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ALL885286
  • 40 Pages
  • December 2016
  • Medical Devices

The fixed dose combination (FDC) of netupitant and palonosetron is a product proposed for the treatment of the most common side effects of chemotherapy-nausea and vomiting. The product is currently in its third stage of trial. Netupitant is a novel and a NK1 receptor antagonist, and palonosetron is a second-generation 5-HT3 receptor antagonist. While netupitant was not available in the drug market earlier, palonosetron drugs were already present under trade names Paloxi, Onicit, and Aloxi. The combination drug is expected to overcome major problems associated with the current mode of treatment of the CINV condition, which involves the use of 5-HT3 receptor antagonists.

The netupitant-palonosetron FDC market is driven by rise in number of patients who undergo chemotherapy. The market is segmented on the basis of patient pool and geography. Currently, pharmaceutical companies are increasingly investing in the further discovery of FDC drugs to achieve increased industry leading breadth and depth of clinical research.

However, factors such as adverse effect of netupitant-palonosetron FDC and high cost of drugs for patients act as restraints for the growth and development of the market. The new approaches and advancement in netupitant-palonosetron FDC market is the development in efficacy and potential of new FDC drugs. The foundation of combination therapy is projected to build up in broad spectrum. Netupitant‐palonosetron, by trade name of Akynzeo, is approved and witnesses an increasing traction in the U.S. and European region.

The classes of drugs used in the treatment of CINV are 5-HT3 receptor antagonists, NK1 receptor antagonists, corticosteroids, dopamine antagonists, benzodiazepines, and cannabinoids. However, Akynzeo is mostly used in the treatment, and is helpful in the prevention of nausea and vomiting due to long-lasting action, with no major adverse effects.

Geographically, the global netupitant-palonosetron FDC market is segmented into North America, Europe, Asia-Pacific, and LAMEA. In terms of growth rate, Asia-Pacific is expected to remain dominant over the forecast period, followed by Europe. North America, on the other hand, is expected to increase at a steady pace due to its steady growth in number of cancer patients opting for chemotherapy.

Major players profiled in the report includes Helsinn Holding S.A., Heron Therapeutics, Inc., Eisai Pharmaceutical Pvt. Ltd., and Tesaro, Inc.

KEY BENEFITS FOR STAKEHOLDERS:

  • This report provides an extensive analysis of the current & emerging market trends and dynamics in the global netupitant‐palonosetron FDC market.
  • This report entails the detailed quantitative analysis of the current trends and future estimations from 2014 to 2022, which assists to identify the prevailing market opportunities.
  • This study evaluates competitive landscape and value chain to understand the competitive environment across the geographies.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.

KEY MARKET SEGMENTS:

  • By Patient Pool
  • By Geography
    • North America
    • Europe
    • Asia-Pacific
    • LAMEA
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.

July 2017 | $5370 | Pre Book Price:$4699

World Anti-Snoring Devices and Snoring Surgery Market - Opportunities and Forecasts, 2014 - 2020

The anti-snoring devices and snoring surgery market has gained traction in the recent years due to growing consciousness about the ill effects of snoring and sleep apnea, and these treatments ...

July 2017 | $5370 | Pre Book Price:$4699

World Sports Medicine Market - Opportunities and Forecasts, 2014 - 2020

The sports medicine market consists of products used by athletes or sportspersons to prevent injuries and protect themselves including devices that boost performance. The product offerings play a crucial role in the rehabilitation, recovery, endurance, and monitoring of athletes in sports.

July 2017 | $5370 | Pre Book Price:$4699

World 3D Printing Medical Devices Market - Opportunities and Forecasts, 2014 - 2020

Large patient population, expansion of distribution networks by the key market players, awareness about benefits of 3D printing technology and its adoption across the emerging countries in Asia-Pacific are the ...

July 2017 | $5370 | Pre Book Price:$4699

World Veterinary Imaging Market - Opportunities and Forecasts, 2014 - 2020

Veterinary diagnostic imaging consists of a non-invasive method of obtaining images of the animal body for the purpose of medical diagnostics. The animals considered for imaging are small companion animals, ...

July 2017 | $5370 | Pre Book Price:$4699

BRIC Diabetes Care Devices Market - Opportunities and Forecasts, 2014 - 2020

Diabetes care devices helps in the management of blood glucose levels caused in patients due to inadequate insulin production or insulin resistance. The Diabetes Care Devices Market in Brazil, Russia, ...

July 2017 | $5370 | Pre Book Price:$4699

2017 © Copyright Big Market Research

View Pricing >>